Brand profile · Biotechnology Research

Esco

Singapore-based Esco operates in Biotechnology Research. Ownership is privately held; it publishes at escolifesciences.com. The record carries four addresses across four office countries. The record counts 1,277 people. Tagged life sciences. Two Singapore registrations (UEN) are candidate matches. Its latest round on record is Series A, US$200.0M. It is listed alongside seven similar brands, mostly in Medical Equipment Manufacturing.

escolifesciences.com LinkedIn

Profile live Privately Held Founded 1978 2 registry matches UEN 4 office countries US$ 200.0M Series A
Registry match · ACRA
Counted staff
1,277
self-reported 1,001–5,000 band
Founded
1978
48 years
Registry matches
2
ACRA
Office countries
4
4 addresses
Funding rounds
1
Series A · Jun 2021 · US$ 200.0M
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entities

1 brand → 2 possible registrationsThese are name matches on ACRA. 2 registrations share this brand's name; which one you contract with is a question for the register.

  • ESCO PTE. LTD.

    UEN198902778C

    Medium confidenceMatched on exact nameACRA

  • ESCO HOLDINGS PTE LTD

    UEN199400187K

    Medium confidenceMatched on exact nameACRA

Legal entities

Esco: 2 registry entitiesEsco is linked to 2 registry entities: ESCO PTE. LTD. (UEN 198902778C, candidate); ESCO HOLDINGS PTE LTD (UEN 199400187K, candidate).EscoESCO PTE. LTD.UEN 198902778CCandidate · Medium confidenceESCO HOLDINGS PTE LTDUEN 199400187KCandidate · Medium confidence
Show as table
ESCO PTE. LTD.UEN 198902778C
ESCO HOLDINGS PTE LTDUEN 199400187K
Confirmed matches0 of 2

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Esco Lifesciences Group is a world-leading manufacturer of laboratory, pharmaceutical equipment, bioprocess tools and IVF medical devices, delivering sustainable workflow solutions to advance global health. Since 1978, the Singapore-based company is committed to excellence, ensuring forward-thinking technology, responsive support, and reliability, making Esco a trusted partner for the life science and medical markets in more than 150 countries.

Our Vision Strategically positioned to bridge the East and West, Esco aspires to become the leading provider of life science and fertility tools, delivering sustainable technologies that foster a healthier, more equitable, and resilient future.

Our Mission We provide cutting-edge, sustainable workflow solutions that empower scientists and innovators to advance global health and enhance quality of life.

ROOTED IN VALUES; DRIVEN BY SUCCESS

Specialties

All 22 specialties
  • Isolators
  • Drug Compounding Facility
  • cDMO
  • Bioprocessing Tools
  • Biosafety Cabinet
  • Ducted & Ductless Fume Hood
  • Laminar Clean Bench
  • Lab Freezer & Refrigerator
  • Lab Animal Workstation
  • CO2 Incubator
  • Lab Incubator & Oven
  • PCR Thermal Cycler
  • Benchtop Incubator
  • IVF Workstation
  • Laboratory Centrifuge
  • Laboratory Shaker
  • PCR Cabinet
  • Time-Lapse Embryo Incubator
  • Life Sciences
  • Ultra-Low Temperature Freezers
  • Biological Safety Cabinets
  • Biosafety

Locations

4
Countries with an office address4 addresses on record
SingaporeprimaryChinaUnited KingdomUnited States

Country footprint

Offices in 4 countriesCountry footprint: 4 countries, primary SG. Codes: SG, CN, GB, US.4 countriesprimary SGSGCNGBUS
Show as table
Countries4
Primary countrySG

All codes: SG CN GB US

Addresses

  • SG19 Changi South Street 1; Singapore, 486779Primary
  • US903 Sheehy Dr; Horsham, Pennsylvania 19044
  • GBUnit 2 R-Evolution @ Gateway 36 Kestrel Way; Barnsley, S Yorks S70 5SZ
  • CNRoom 1211, Jiahe International Building; No.1, Lane 66, Huayuan Road; Hongkou District, Shanghai 200083

Grid intelligence Members

Funding

Last round · 26 June 2021US$ 200.0MSeries A · investors: Vivo Capital, Novo Holdings
Rounds1
Round typeSeries A · venture round
Amount (USD)200,000,000
Stage rank3
Investors named2
Since last round4 yr 6 mo

Funding

1 funding roundFunding timeline. Latest round 26 Jun 2021: Series A, US$ 200.0M.19782026Series AUS$ 200.0M1 round
Show as table
Rounds1
Axis1978 to 2026
Series A · 26 Jun 2021US$ 200.0M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

4 employee profiles on record · names withheld.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entities operate under Esco?

Two Singapore entities on ACRA. ESCO PTE. LTD. (UEN 198902778C) and ESCO HOLDINGS PTE LTD (UEN 199400187K). Both medium confidence.

How many people work at Esco?

The record holds 1,277 counted staff profiles at January 2026, inside the self-reported 1,001–5,000 band.

Where does Esco have offices?

Four addresses on record across 4 countries. Primary: 19 Changi South Street 1, Singapore 486779.

Has Esco raised funding?

One round. Latest 26 June 2021: Series A, US$200,000,000, investors Vivo Capital and Novo Holdings.

What does Esco list as its specialties?

22 tags on the brand's own list, among them life sciences.

Which companies are listed alongside Esco?

83 profiles list Esco as a peer — 99th percentile in Biotechnology Research. It lists ten peers of its own. Esco Utama and Esco Medical list it back.

What is Esco's website?

escolifesciences.com